3
Revista Iberoamericana de Educación e Investigación en Enfermería

Revista Iberoamericana de Educación e Investigación en Enfermería

OCTUBRE 2021 N° 4 Volumen 11

Anorectic effects of the peptide yy in obesity management interventions; an integrative review

Section: Reviews

How to quote

Corona-Ramírez VM, Cárdenas-Rodríguez ML, García-Campos ML, Beldrán-Campos V. Efectos anorexígenos del péptido YY en intervenciones para el manejo de la obesidad: revisión integrativa. Rev. iberoam. Educ. investi. Enferm. 2021; 11(4):17-28.

Authors

1 Víctor Manuel Corona-Ramírez, 2 Mtra. Maritza Lizeth Cárdenas-Rodríguez, 3 Dra. María de Lourdes García-Campos, 3 Dr. Vicente Beltrán-Campos

Position

1 Estudiante del Maestría en Ciencias de Enfermería de la Universidad de Guanajuato. Campus Celaya-Salvatierra.  2 Estudiante del Doctorado en Ciencias de Enfermería de la Universidad de Guanajuato, Campus Celaya-Salvatierra. 3 Doctor/a. Profesor/a de la Universidad de Guanajuato. Campus Celaya-Salvatierra. México.

Contact email: vm.coronaramirez13@gmail.com

Abstract

Introduction: obesity is defined as an abnormal or excessive fat accumulation, which can be damaging and harmful for health. In the search for an effective alternative treatment, peptide hormones such as the peptide YY (a3-36) have been studied for their potential effect on energy intake regulation and impact on appetite.
Objective: to analyse the anorectic effects of the peptide YY (a3-36) as obesity treatment.
Methodology: a literature search was conducted in five databases: PubMed (NCBI), Cochrane Library, BVS, WorldWideScience.org and Microsoft Academic. The MeSH terms used in the search were: “péptido YY” (peptide YY) y (AND) “obesidad” (obesity), and the publication period was between 2015 and 2020.
Results: the English language prevailed among articles. Six articles were found in PubMed, two in Cochrane Library, four in BVS, one in WorldWideScience.org, and two in Microsoft Academic; nine of them were clinical trials, three trials conducted in rats and the rest in human beings, from adolescents to adults.
Conclusions: higher levels of peptide YY (a3-36), either through administration or secretion stimulation, have demonstrated their efficacy for the obesity reduction. Clinical trial results are promising; however, more studies are required to become a driving factor in their application in human beings, and particularly in the paediatric population.

Keywords:

peptide YY; obesity; peptides; hormones; obesity management (MeSH)

Versión en Español

Título:

EFECTOS ANOREXÍGENOS DEL PÉPTIDO YY EN INTERVENCIONES PARA EL MANEJO DE LA OBESIDAD: REVISIÓN INTEGRATIVA

Artículo completo no disponible en este idioma / Full article is not available in this language

Bibliography

  1. Organización Mundial de la Salud (OMS). Obesidad y Sobrepeso [internet]. Ginebra: OMS; 2020 [citado 29 jun 2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight
  2. Hersoug L, Møller P, Loft S. Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: Implications for inflammation and obesity. Obes Rev. [internet] 2016 [citado 29 jun 2021]; 17(4):297-312. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/obr.12370
  3. Choque T, Tamashiro E. Role of prebiotics in regulation of microbiota and prevention of obesity. Food Res Int. [internet] 2018 [citado 29 jun 2021]; 113:183-88. Disponible en: https://www.sciencedirect.com/science/article/pii/S0963996918305416
  4. Pérez-Herrera A, Cruz M. Situación actual de la obesidad infantil en México. Nutr Hosp. 2019; 36(2):463-9. Doi: http://dx.doi.org/10.20960/nh.2116
  5. Molina C, Cifuentes G, Martínez C, Mancilla R, Díaz E. Disminución de la grasa corporal mediante ejercicio físico intermitente de alta intensidad y consejería nutricional en sujetos con sobrepeso u obesidad. Rev Med Chile. [internet] 2016 [citado 29 jun 2021]; 144:1254-9. Disponible en: https://scielo.conicyt.cl/pdf/rmc/v144n10/art03.pdf
  6. Nguo K, Bonham M, Truby H, Barber E, Brown J, Huggins C. Effect of Macronutrient Composition on Appetite Hormone Responses in Adolescents with Obesity. Nutrients. 2019; 5(11):340. Doi: http://doi.org/10.3390/nu11020340
  7. Lafferty R, Flatt P, Irwin N. Emerging therapeutic potential for peptide YY for obesity-diabetes. Peptides. 2018; 100:269-74. Doi: http://doi.org/10.1016/j.peptides.2017.11.005
  8. Gribble F, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinole. 2019; 15(4):226-37. Doi: http://doi.org/10.1038/s41574-019-0168-8
  9. Witjaksono F, Simadibrata M, Lukito W, Wijaya A, Nurwidya F. Profiles of peptide YY and ghrelin, levels of hunger and satiety, and ad libitum intake in obese and non-obese Indonesian women. Rom J Intern Med. 2018; 57(1):15-22. Doi: http://doi.org/10.2478/rjim-2018-0027
  10. Kairupan T, Amitani H, Cheng K, Runtuwene J, Asakawa A, Inui A. Role of gastrointestinal hormones in feeding behavior and obesity treatment. J Gastroenterol. 2016; 51:93-103. Doi: http://doi.org/10.1007/s00535-015-1118-4
  11. Carranza Gli. Fisiología del apetito y el hambre. Enfermería investiga: investigación, vinculación, docencia y gestión. [internet] 2016 [citado 29 jun 2021]; 1(3):117-23. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=6194254
  12. Feldman M, Lawrence S, Lawrence J, Sleisenger, Fordtran. Enfermedades Digestivas y hepatitas. Fisiopatología, diagnóstico y tratamiento. 10ª ed. Barcelona: Elsevier; 2018.
  13. Grande-Orive J, Granda-Beltrán A, Segrelles-Calvo G. Relación de la Leptina, la orexina, el Péptido YY, y la ghrelina con la recaída al dejar de fumar. Arch Bronconeumol. 2017; 53(10):543-4. Doi: http://doi.org/10.1016/j.arbres.2017.04.017
  14. Remmel L, Tillmann V, Purge P, Lätt E, Jürimäe J. Associations of serum leptin, ghrelin, and peptide YY levels with physical activity and cardiorespiratory fitness in adolescent boys with different bmi values. Biol Sport. 2017; 34:345-52. Doi: http://doi.org/10.5114/biolsport.2017.69822
  15. Rojas-Marcos PR. Modificaciones en las hormonas gastrointestinales tras cirugía bariátrica, [Tesis Doctoral]. Madrid; E-Prints Complutense; 2017. p. 60.
  16. Cheng H, Sainsbury A, Garden F, Sritharan M, Paxton K, Luscombe G, et al. Ghrelin and peptide YY change during puberty: relationships with adolescent growth. development, and obesity. Clin endocrinol metab. 2018, 103(8):2851-60 Doi: http://doi.org/10.1210/jc.2017-01825
  17. Nishizawa N, Niida A, Adachi Y, Masuda Y, Kumano S, Yokoyama K, et al. Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice. Bioorganic & medicinal chemistry letters. 2017;  27(16):3829-32. Doi: http://doi.org/10.1016/j.bmcl.2017.06.055
  18. Parvaresh E, Loh T, Baig S, Chhay V, Huang S, Caleb J, et al. A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men. PLoS ONE. 2018; 13(1):e0191609. Doi: http://doi.org/10.1371/journal.pone.0191609
  19. Shao J, Chen M, Kuehl P, Hochhaus G. Pharmacokinetic and pharmacodynamic modeling of gut hormone peptide YY (3–36) after pulmonary delivery. Drug Development and Industrial Pharmacy 2019; 45(7):1101-10. Doi: http://doi.org/10.1080/03639045.2019.1593443
  20. Svane M, Jorgensen N, Bojsen-Møller K, Dirksen C, Nielsen S, Kristiansen V, et al. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. IJO. 2016; 40:1699-706. Doi: http://doi.org/10.1038/ijo.2016.121
  21. Tan T, Behary P, Tharakan G, Minnion J, Al-Najim W, Wewer-Albrechtsen N, et al. The effect of a subcutaneous infusion of GLP-1, OXM and PYY on Energy intake and Expenditure in Obese volunteers. The Journal of Clinical Endocrinology & Metabolism. Doi: http://doi.org/10.1210/jc.2017-00469
  22. Palacios-Alaiz E. Regulación neuro hormonal de la obesidad. An Real Acad Farm. [internet] 2016 [citado 29 jun 2021]; 82:87-105. Disponible en: https://analesranf.com/wp-content/uploads/2016/82_ex2/82ex2_08.pdf
  23. Ghazzawi H, Mustafa S. Effect of high-protein breakfast meal on within-day appetite hormones: peptide YY, glucagone like peptide-1 in adults. Clinical Nutrition Experimental. 2019; 28:111-22. Doi: http://doi.org/10.1016/j.yclnex.2019.09.002
  24. Tischmann L, Drummen M, Gatta-Cherifi B, Raben A, Fogelholm M, Hartmann B, et al. Efectos de una dieta de alto contenido en proteínas/moderada en el apetito, los péptidos intestinales y los endocannabinoides: un estudio de vista previa. Nutrientes. MDPI AG; 2019 Sep 21; 11(10):2269. Doi: http://dx.doi.org/10.3390/nu11102269
  25. Gumus-Balikcioglu P, Balikcioglu M, Muehlbauer MJ, Purnell JQ, Broadhurst D, Freemark M. Regulación de macronutrientes de ghrelina y péptido YY en obesidad pediátrica y síndrome de Prader-Willi. JCEM. 2015; 100(10):3822-31. Doi: http://doi.org/https://doi.org/10.1210/jc.2015-2503
  26. Witjaksono F, Lukito W, Wijaya A. El efecto del desayuno con diferente composición de macronutrientes en PYY, ghrelina, y ad libitum ingesta 4 h después del desayuno en mujeres obesas indonesias. De BMC Res. 2018. Notas 11, No. 787. Doi: https://doi.org/10.1186/s13104-018-3895-3
  27. Hu T, Yao L, Reynolds K, Niu T, Li S, Whelton P, et al. The Effects of a Low-Carbohydrate Diet on Appetite: A Randomized Controlled Trial, NMCD. 2016; 26(6):476-88 Doi: http://dx.doi.org/10.1016/j.numecd.2015.11.011